Pharmacogenomic Testing to Optimize Antidepressant Drug Therapy

Clinical trial NCT03591224 · COMPLETED

Trial details

NCT number: NCT03591224
Sponsor: John Papastergiou Pharmacy Ltd
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Depression Anxiety Major Depressive Disorder Generalized Anxiety Disorder Mood Disorders

Start date: 2018-04-17
Primary completion: 2019-12-31
Enrollment: 213

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.